Scarica l'app Stockscreener
58.45
3.19%
-1.055
Anaptysbio Inc Borsa (ANAB) Ultime notizie
Daily Brief United States: SpaceX, Crude Oil, DPC Holdings, CRB Commodity Index, Vistra , AnaptysBio Inc, Kardigan, Aes Corp, GE Vernova , Biomarin Pharmaceutical and more - Smartkarma
ANAB (NASDAQ: ANAB) affiliate files Form 144 to sell 20,000 shares - Stock Titan
AnaptysBio, Inc. (NASDAQ:ANAB) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
ANAB (NASDAQ: ANAB) affiliate files Form 144 listing multiple share dispositions - Stock Titan
Q2 Earnings Forecast for AnaptysBio Issued By HC Wainwright - MarketBeat
AnaptysBio, Inc. Stock 12‑Month Price Target Raised to $81.5, Implies 50% Upside - TradingView
Morgan Stanley (ANAB) plans 35,000-share sale; multiple insider dispositions listed - Stock Titan
[144] ANAPTYSBIO, INC SEC Filing - Stock Titan
ANAB Assumed by HC Wainwright & Co. -- Rating Set to Buy - GuruFocus
H.C. Wainwright initiates AnaptysBio stock coverage with buy rating By Investing.com - Investing.com Nigeria
H.C. Wainwright initiates AnaptysBio stock coverage with buy rating - Investing.com
H.C. Wainwright Initiates AnaptysBio(ANAB.US) With Buy Rating, Announces Target Price $95 - Moomoo
AnaptysBio Coverage Assumed by HC Wainwright & Co. at Buy - Moomoo
AnaptysBio, Inc. $ANAB Shares Acquired by BNP Paribas Financial Markets - MarketBeat
ANAB (ANAB) insider files Form 144 to sell 20,000 shares via option exercise - Stock Titan
ANAB (NASDAQ: ANAB) Form 144 shows Dennis Mulroy selling multiple lots - Stock Titan
ANAB (NASDAQ: ANAB) director reports multiple stock-option sales, dates listed - Stock Titan
ANAB insider resale filed: 20,000 shares via option (ANAB) - Stock Titan
AnaptysBio earnings up next: First report as royalty company - Investing.com
AnaptysBio (NASDAQ:ANAB) Lowered to "Hold" Rating by Zacks Research - MarketBeat
20,000 ANAB Shares Registered; Dennis Mulroy Sold Multiple Lots (ANAB) - Stock Titan
ANAB (NASDAQ) affiliate to sell 20,000 shares via cash option exercise - Stock Titan
Affiliate of ANAB (NASDAQ: ANAB) to sell 7,691 shares after option exercise - Stock Titan
AnaptysBio posts Form 8937 on tax treatment of First Tracks spin-off dividend - TradingView
Spin-off dividend tax info posted by AnaptysBio (NASDAQ: ANAB) - Stock Titan
ANAB proposes sale of 15,000 shares (NASDAQ: ANAB) - Stock Titan
ANABAnaptysBio Inc Stock Price and Quote - Finviz
AnaptysBio, Inc.Common Stock (NQ: ANAB - FinancialContent
ANAB (NASDAQ: ANAB) director reports May sales and 10,264‑share exercise - Stock Titan
Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), GeoVax Labs (GOVX) and Vir Biotechnology (VIR) - The Globe and Mail
AnaptysBio (ANAB) may find a bottom soon, here's why you should buy the stock now - MSN
Dennis Mulroy files Form 144 to sell shares (ANAB) - Stock Titan
Leerink Partners Maintains AnaptysBio(ANAB.US) With Buy Rating - Moomoo
ANAB (ANAB) Form 144: Insider-linked 10,000-share sale disclosed - Stock Titan
AnaptysBio Inc. (ANAB) Q1 2026 Earnings: Significant EPS Miss Amid Clinical ProgressSpecial Dividend Alert - newsline.com
J.P. Morgan Maintains AnaptysBio(ANAB.US) With Buy Rating, Raises Target Price to $70 - Moomoo
Affiliate sale notice: ANAB (NASDAQ: ANAB) plans 10,000-share sale - Stock Titan
AnaptysBio Inc (ANAB) Stock Price, Quote, News & History - Benzinga
Wall Street analysts see a 38.75% upside in AnaptysBio (ANAB): Can the stock really move this high? - MSN
AnaptysBio (NASDAQ: ANAB) moves fiscal year-end to June 30, 2026 - Stock Titan
AnaptysBio, Inc. Approves Change in Fiscal Year-End from December 31 to June 30 - marketscreener.com
Is AnaptysBio (ANAB) outperforming other medical stocks this year? - MSN
Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year? - Yahoo Finance UK
AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
TRAXV SEC FilingsFirst Tracks Biotherapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
ANAB Technical Analysis | Trend, Signals & Chart Patterns | ANAPTYSBIO INC (NASDAQ:ANAB) - ChartMill
Dennis Mulroy (ANAB) files to sell 10,000 shares via option exercise - Stock Titan
Wall Street Analysts See a 38.75% Upside in AnaptysBio (ANAB): Can the Stock Really Move This High? - Yahoo Finance
AnaptysBio (ANAB) Valuation After Spin Off And Shift To Royalty Focused Model - Sahm
1.70%
0.89%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):